Erik Strömqvist

Erik Strömqvist

Director/Board Member chez STUDSVIK AB

54 ans
Health Technology
Commercial Services
Electronic Technology

Profil

Erik Strömqvist is currently the Chairman at MedTrace Pharma.
AS since 2024.
He is also an Independent Director at Studsvik AB since 2021.
In addition, he holds positions as a Director at Xvivo Perfusion AB, Celcibus AB, and Atley Solutions AB.
Furthermore, he serves as the Chief Operating Officer at Swiss Nuclides AG.
Previously, Mr. Strömqvist worked as a Director at Celcibus AB from 2020 to 2023.
He also held the position of President at Swiss Nuclides Sweden AB.
Prior to that, he was the General Manager-Cyclotrons & TRACERcenter at GE Healthcare AB from 2009 to 2020.

Postes actifs de Erik Strömqvist

SociétésPosteDébut
STUDSVIK AB Director/Board Member 23/06/2021
XVIVO PERFUSION AB Director/Board Member -
Chief Operating Officer -
Director/Board Member 01/06/2021
Chairman 01/01/2024
Tous les postes actifs de Erik Strömqvist

Anciens postes connus de Erik Strömqvist

SociétésPosteFin
Director/Board Member 01/06/2023
Corporate Officer/Principal 01/06/2020
Swiss Nuclides Sweden AB President -
Voir l'expérience en détail de Erik Strömqvist

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Erik Strömqvist

Relations

44

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
STUDSVIK AB

Commercial Services

XVIVO PERFUSION AB

Health Technology

Entreprise privées6

Health Technology

Health Technology

Commercial Services

Electronic Technology

Health Services

Swiss Nuclides Sweden AB

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Erik Strömqvist